24H for Consultation & Appointment
4008-210-277
Chest Pain Hotline
021-6700-7783
语言
24H Hotline:
4008-210-277
Chest Pain Hotline:
021-6700-7783
Mini Shop
Traffic Routes
Panoramic VR guide
Thoracic Tumor Center

The Thoracic Surgery/Thoracic Tumor Center at DeltaHealth Cardiovascular Hospital · Shanghai has been established by a team led by Professor Zhao Heng, who is an Honorary Director and Ph.D Supervisor in Thoracic Surgery at Shanghai Chest Hospital affiliated to Shanghai Jiaotong University. The center also features collaborative input from multiple prominent oncology specialists. Adhering to national standard methodologies and techniques, this center offers comprehensive management for various thoracic tumor conditions. It functions as a complete diagnostic and treatment system, providing services such as tumor diagnosis, surgical intervention, chemotherapy, radiotherapy, interventional treatments (planned), immunotherapy, and targeted drug therapy.


The Center features an internationally professional expert medical team dedicated to delivering high-quality healthcare services. Based on advanced disease management philosophies, clinical diagnostic and treatment guidelines of international standard, and the integration of forefront research outcomes, we offer various treatment modalities to patients, particularly multidisciplinary consultation and treatment for thoracic tumors (e.g., lung, mediastinal, and esophageal tumors). The Center employs various chemotherapy modalities, including neoadjuvant chemotherapy, concurrent chemoradiotherapy, and adjuvant chemotherapy. Concurrently, the interventional treatment platform will conduct complex biopsy procedures and various interventional embolization therapies. This comprehensive approach ensures the provision of high-quality medical services for patients across early, middle, and late stages of disease.


Expertise in Pulmonary Diseases, including:

1. Pulmonary Nodules and Lung Cancer: Precise diagnosis and minimally invasive surgery for lung nodules

Comprehensive treatment for early, middle, and late-stage lung cancer (surgery + neoadjuvant/adjuvant therapy + targeted therapy/immunotherapy/ablation/radiotherapy)

2. General Thoracic Diseases: Conventional management of common conditions such as pneumothorax, pleural effusion, and bronchiectasis

Minimally invasive correction for chest wall deformities (pectus excavatum/pectus carinatum)

3. Highly Complex Thoracic Tumors: Radical resection and complex reconstruction for trachea/mediastinal/esophageal tumors with large vessel or carina invasion

4. Diagnosis and Treatment of Mediastinal Diseases: Thymoma, myasthenia gravis, neurogenic tumors, etc.

5. Esophageal Diseases: Minimally invasive surgery and comprehensive management (chemotherapy/immunotherapy/radiotherapy) for esophageal cancer

Treatment for benign esophageal conditions (leiomyoma/stricture/rupture)

6. Functional Disorders: Minimally invasive treatment for hyperhidrosis


Respiratory Diseases, including:

1. Pulmonary Infectious Diseases: Pneumonia, pulmonary abscess, upper respiratory tract infections, acute tracheobronchitis, etc.

2. Airway Diseases: Bronchiectasis, bronchial asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), etc.

3. Pulmonary Tumors: Primary bronchogenic carcinoma, pulmonary metastases, benign lung tumors


Treatable Diseases:Pulmonary nodules and lung cancer, general thoracic diseases, highly complex thoracic tumors, mediastinal diseases, esophageal diseases, and pulmonary functional diseases; pulmonary infectious diseases, airway diseases, pulmonary tumors and other respiratory diseases
Key Physician Leaders
Prof. Heng Zhao
M.D. Ph.D. FACS
Chinese, English, Shanghainese
Introduction:Prof.Heng Zhao is honorary director and chief physician of Thoracic Surgery Department of Shanghai Chest Hospital affiliated to Shanghai Jiaotong University. He is a professor and doctoral supervisor. He is the standing member of Chinese Society for Thoracic and Cardiovascular Surgery , vice president of Endoscopy Committee under Chinese Medical Doctor Association, deputy director of Tracheal Disease Research Center of Shanghai Lung Cancer Research Institute,FormerVicepresident of Thoracic Surgery Committee under Chinese Research Hospital Association, FormerPresident of Shanghai Society of Thoracic Surgery, director of Lung Cancer Surgery Expert Group under Shanghai Cancer Foundation, Fellow American College of Surgeons, member of Ministry of Health(MOH) Clinical Pathway (Thoracic Surgery) Review Committee, expert panel of MOH Thoracic Surgery Technology Professional Title Examination, President of International Chinese Society of Thoracic Surgery, Expert panel of Shanghai Judicial Expertise, Editor of Chinese Journal of Thoracic Cardiovascular Surgeon, deputy editor-in-chief of Chinese Journal of Thoracic Surgery (E-version), Editor of Chinese Journal of Surgery, Editor of Shanghai Medical Journal, Editor of Journal of Clinical Oncology, Editor of Chinese Medical Journal (English version).Expertise: Surgical treatment of common thoracic diseases such as tracheal diseases, lung cancer, esophageal cancer, mediastinal tumors, etc.and especially good at difficult thoracic surgery such as trachea, complex lung cancer, and surgical reconstruction of chest wall defects. His academic focuses are the study of tracheal substitutes, surgical treatment of and fundamental research of lung cancer, thoracoscopy and robot-assisted minimally invasive surgery for the treatment of chest diseases and lung transplantation. He has rich clinical experience in thoracic surgery and surgicaloncology.
Professionals